Orphenadrine Citrate
6 NDCs across 4 manufacturers|6 Generic,0 Brand
Orphenadrine Citrate is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Orphenadrine Citrate across 70,000 claims for 40,000 beneficiaries.
Orphenadrine Citrate is available as 6 NDCs from 4 manufacturers (6 generic, 0 brand), with NADAC prices from $0.34 to $0.45 per EA — a 35% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
4
competing in market
Price Spread
$0.34 – $0.45
per EA, 4 of 6 NDCs
7d Activity
avg -0.7% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Lupin Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Muscle Relaxant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing ORPHENADRINE CITRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ORPHENADRINE 60 MG/2 ML VIAL | $7.0744 per ML | — |
ORPHENADRINE 60 MG/2 ML VIAL | $5.7303 per ML | +0.36% |
ORPHENADRINE ER 100 MG TABLET | $0.4536 per EA | -1.08% |
ORPHENADRINE ER 100 MG TABLET | $0.4536 per EA | -1.08% |
ORPHENADRINE ER 100 MG TABLET | $0.4536 per EA | -1.08% |
ORPHENADRINE ER 100 MG TABLET | $0.3361 per EA | — |
Frequently Asked Questions
What is Orphenadrine Citrate used to treat?
Orphenadrine Citrate is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.
When did Orphenadrine Citrate become available as a generic?
FDA approved the first generic Orphenadrine Citrate (ANDA) on Jan 1, 1982. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Orphenadrine Citrate?
In 2024, Medicare Part D spent $2 million on Orphenadrine Citrate across 70,000 claims for 40,000 beneficiaries.
How many Orphenadrine Citrate products are on the market?
The Orphenadrine Citrate drug market contains 6 NDCs from 4 manufacturers — 6 generic and 0 brand products.
What is the price range for Orphenadrine Citrate?
NADAC reference prices for Orphenadrine Citrate range from $0.3361 to $0.4536 per EA — a 35% difference between cheapest and most expensive. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Orphenadrine Citrate?
4 manufacturers list Orphenadrine Citrate in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (3), Hikma Pharmaceuticals USA Inc. (1), Sagent Pharmaceuticals (1), Sandoz Inc. (1).
How has the price of Orphenadrine Citrate changed recently?
Over the past 7 days, 1 Orphenadrine Citrate NDC rose and 3 fell, with a market-wide average change of -0.7%.